Business Standard

Between lab and jab: Miles to go before India has a Covid-19 vaccine

There is a reason why most of those involved in the race for a vaccine are studiously non-committal about a timeline

Coronavirus, vaccine, covid, drugs, tests, clinical trials
Premium

As of now, three vaccine candidates are the front-runners in India: Zydus Cadila, Bharat Biotech and Serum Institute for the Oxford-AstraZeneca vaccine

Ruchika ChitravanshiSohini Das New Delhi/Mumbai
The quest for a Covid-19 vaccine may have started in the laboratories but that’s only the start of a long process that involves the government and private sector working on the other issues that bridge the gap from lab to jab — from manufacturing and manpower to logistics and distribution priorities.

That is why most of those involved in the race for a vaccine are studiously non-committal about a timeline. The 2020-end deadline that is being bandied about in the public domain is purely speculative.  
 
Balram Bhargava, chief of Indian Council of Medical Research, in a recent interview with Business

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in